Daratumumab for the Treatment of Patients With AL Amyloidosis
Clinical trial NCT02841033 · COMPLETED
Trial details
- NCT number
- NCT02841033
- Sponsor
- Boston Medical Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-20
- Primary completion
- 2020-05-28
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.